Browsing by Author Crossan, C

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)
2016Cost effectiveness of case-finding strategies for drug treatment in primary prevention of cardiovascular disease: a modelling studyCrossan, C; Lord, J; Ryan, R; Nherera, L; Marshall, T
2015Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluationCrossan, C; Tsochatzis, EA; Longworth, L; Gurusamy, K; Davidson, B; Rodríguez-Perálvarez, M; Mantzoukis, K; O'Brien, J; Thalassinos, E; Papastergiou, V; Burroughs, A
2016Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluationCrossan, C; Tsochatzis, EA; Longworth, L; Gurusamy, K; Papastergiou, V; Thalassinos, E; Mantzoukis, K; Rodriguez-Peralvarez, M; O'Brien, J; Noel-Storr, A; Papatheodoridis, GV; Davidson, B; Burroughs, AK
2014Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis CTsochatzis, EA; Crossan, C; Longworth, L; Gurusamy, K; Rodriguez-Peralvarez, M; Mantzoukis, K; O'Brien, J; Thalassinos, E; Papastergiou, V; Noel-Storr, A; Davidson, B; Burroughs, AK
2014Cost-effectiveness of upcoming treatments for hepatitis C: We need to get the models rightTsochatzis, EA; Crossan, C; Longworth, L
2013Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) projectLord, J; Willis, S; Eatock, J; Tappenden, P; Trapero-Bertran, M; Miners, A; Crossan, C; Westby, M; Anagnostou, A; Taylor, SJE; Mavranezouli, I; Wonderling, D; Alderson, P; Ruiz, F
2013Economic modelling of diagnostic and treatment pathways in NICE clinical guidelines: the MAPGuide projectLord, J; Willis, S; Eatock, J; Tappenden, P; Trapero-Bertran, M; Miners, A; Crossan, C; Westby, M; Anagnostou, A; Taylor, S; Mavranezouli, I; Wonderling, D; Alderson, P; Ruiz, F
2015Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation: A Single Technology Appraisal. Evidence Review Group Report to NICEGreenhalgh, J; Longworth, L; Crossan, C; Singh, J; Bagust, A; Beale, S; Richardson, M; Banks, L; Kotas, E; Hall, M
2016A Protocol for an economic evaluation of a polypill in patients with established or at high risk of cardiovascular disease in a UK NHS setting: RUPEE (NHS) studyCrossan, C; Dehbi, HM; Thom, S; Poulter, N; Williams, H; Rodgers, A; Jan, S; Lord, J